Dupont Capital Management Corp acquired a new position in Healthequity Inc (NASDAQ:HQY) in the fourth quarter, HoldingsChannel reports. The fund acquired 4,931 shares of the company’s stock, valued at approximately $294,000.
A number of other hedge funds have also recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Healthequity by 5.9% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,953 shares of the company’s stock worth $236,000 after purchasing an additional 220 shares in the last quarter. Crossmark Global Holdings Inc. grew its position in shares of Healthequity by 6.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 5,140 shares of the company’s stock valued at $307,000 after acquiring an additional 320 shares during the period. Retirement Systems of Alabama grew its position in shares of Healthequity by 0.3% during the 4th quarter. Retirement Systems of Alabama now owns 133,268 shares of the company’s stock valued at $7,949,000 after acquiring an additional 372 shares during the period. Legacy Financial Advisors Inc. bought a new position in shares of Healthequity during the 4th quarter valued at approximately $28,000. Finally, Arizona State Retirement System grew its position in shares of Healthequity by 1.3% during the 4th quarter. Arizona State Retirement System now owns 38,958 shares of the company’s stock valued at $2,324,000 after acquiring an additional 497 shares during the period. 91.44% of the stock is owned by institutional investors and hedge funds.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction that occurred on Thursday, December 20th. The shares were sold at an average price of $60.28, for a total value of $241,120.00. Following the sale, the vice president now directly owns 82,000 shares in the company, valued at approximately $4,942,960. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Frank Corvino sold 1,778 shares of the stock in a transaction that occurred on Monday, December 10th. The stock was sold at an average price of $67.78, for a total transaction of $120,512.84. Following the completion of the sale, the director now owns 5,051 shares in the company, valued at $342,356.78. The disclosure for this sale can be found here. Insiders have sold a total of 11,846 shares of company stock worth $751,308 over the last 90 days. 4.00% of the stock is currently owned by corporate insiders.
Healthequity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, December 4th. The company reported $0.22 EPS for the quarter, beating the Zacks’ consensus estimate of $0.20 by $0.02. The company had revenue of $70.50 million for the quarter, compared to analysts’ expectations of $69.60 million. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. Healthequity’s revenue was up 24.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.17 EPS. As a group, research analysts predict that Healthequity Inc will post 0.91 earnings per share for the current fiscal year.
A number of research analysts have recently weighed in on the stock. BidaskClub raised shares of Healthequity from a “buy” rating to a “strong-buy” rating in a research report on Thursday, November 1st. Cantor Fitzgerald increased their target price on shares of Healthequity from $80.00 to $82.00 and gave the company a “neutral” rating in a research report on Thursday, December 6th. SunTrust Banks downgraded shares of Healthequity from a “buy” rating to a “hold” rating and reduced their target price for the company from $105.00 to $90.00 in a research report on Thursday, December 6th. ValuEngine cut shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, December 5th. Finally, Zacks Investment Research cut shares of Healthequity from a “buy” rating to a “hold” rating in a research note on Tuesday, November 20th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $89.62.
COPYRIGHT VIOLATION WARNING: This article was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The correct version of this article can be read at https://www.tickerreport.com/banking-finance/4165738/4931-shares-in-healthequity-inc-hqy-purchased-by-dupont-capital-management-corp.html.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More: How Does the Quiet Period Work?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.